Scientific Program

Poster Presentation

**This is tentative, and subject to change at a later time.
(As of August 16, 2019)
Sep 5 (Thu) 07:00-07:40

[PP01] Poster Presentation

Hall B2, 1F
Chairperson(s)
Gi Hong Choi (Korea), Mohammed Ballal (Australia)
07:00-07:05
Do Inflammatory and Nutritional Status Affect the Recurrence and Survival of Patients with Hepatocellular Carcinoma Following Hepatectomy? Tung-Teng Li (Taiwan)
07:05-07:10
Time-Varying Prognostic Impact of Primary Tumor Grade and Sidedness in Colorectal Liver Metastases Darren Chua (Singapore)
07:10-07:15
Preoperative Controlling Nutritional Status Plus Tumor Burden (CONUT-TB) Score for Assessment of Prognosis After Curative Liver Resection for Hepatocellular Carcinoma Yasuyuki Fukami (Japan)
07:15-07:20
Pre Operative Predictors for Cysto Biliary Communication in Patients with Hepatic Hydatid Disease Shreedevi KN (India)
07:20-07:25
Impact of SS18L1 Polymorphism in Predicting Prognosis of Hepatocellular Carcinoma Min-Su Park (Korea)
07:25-07:30
Can TACE + SBRT Be Neoadjuvant Therapy for HCC? Tang Yu Lam (Hong Kong)
07:30-07:35
Evaluating the Significance of Chemokine Receptor 5 in Hepatitis A Virus Infection and Its Utility as a Target for Clinical intervention Vargab Baruah (India)
07:35-07:40
Super-Selective Intra-Arterial Hepatic Injection of Indocyanine Green (ICG) for Fluorescence Image-Guided Segmental Positive Staining: Preliminary Data Yueh-Wei Liu (Taiwan)
Sep 5 (Thu) 07:00-07:40

[PP02] Poster Presentation

Hall B2, 1F
Chairperson(s)
Je Ho Ryu (Korea), Taizo Hibi (Japan)
07:00-07:05
TGF-β Downstream Smad3 and MAPK Signaling Are Mutually Antagonistic in Liver Progenitor Cells Ze-yang Ding (China)
07:05-07:10
Performance of Hong Kong Liver Cancer Staging System in Patients of Hepatocellular Carcinoma Treated with Surgical Resection: An Indian Validation Study Amir Parray (India)
07:10-07:15
Synchronous Resection of Colorectal Cancer Liver Metastasis: Propensity Score Matching of Open Versus Minimally Invasive Surgery Seoung Yoon Rho (Korea)
07:15-07:20
Metabolic Signature to Predict Recurrence After Curative Resection of Hepatocellular Carcinoma: A Bench-to-Bedside Study Tian Yang (China)
07:20-07:25
Anatomic Resection, Surgical Margin Positivity and Primary Tumor Site Do Not Have Effect on Overall Survival After Liver Resection for Colorectal Metastases Onur Elvan Kirimker (Turkey)
07:25-07:30
A Propensity Score Analysis of Surgical Outcomes Between Laparoscopic Versus Open Liver Resection : An Initial Experience from Single Center Worakitti Lapisatepun (Thailand)
07:30-07:35
Dynamical Detection and Characterization of Circulating Tumor DNA in Patients with Hepatocellular Carcinoma Jingfeng Liu (China)
07:35-07:40
Is Laparoscopic Liver Resection for Hepatocellular Carcinoma Safe for Obese Patients? Youngin Yoon (Korea)
Sep 5 (Thu) 07:00-07:40

[PP03] Poster Presentation

Hall B2, 1F
Chairperson(s)
Hyung Joon Han (Korea), Paleswan Joshi Lakhey (Nepal)
07:00-07:05
Outcomes of Hepatic Resection at St. Luke’s Medical Center, Philippines: A Five-Year Case Series Maria Millicent Carino (Philippines)
07:05-07:10
Evaluation of Infrahepatic Inferior Vena Cava Clamping in Robotic Liver Resection: A Pair-Matched Comparison Study Peng Zhu (China)
07:10-07:15
Mammalian Target of Rapamycin (mTOR) and Autophagy in Hepatitis C Virus-Related Hepatocellular Carcinoma: Relation to Tumor Progression Hoda El Aggan (Egypt)
07:15-07:20
Utility of ICG Fluorescence Imaging for Laparoscopic Anatomical Liver Resection Masaki Ueno (Japan)
07:20-07:25
Hepatobiliary Tuberculosis: A 10 Years Retrospective Study in Sarawak General Hospital, Sarawak Malaysia Mohd Faiz Idris (Malaysia)
07:25-07:30
Laparoscopic Anatomical Hepatectomy with ICG Fluorescence Staining By Lap-Ultrasound and 3D Visualization Guided Portal Branch Puncture Approach Xiaoying Wang (China)
07:30-07:35
Postero-Superior Liver Segments Resection for Colorectal Liver Metastases. Psm Based Comparative Analysis of Minimally Invasive and Open Resections Mikhail Efanov (Russia)
07:35-07:40
Parenchymal-Sparing Liver Resections (Open and Laparoscopic) in Metastatic Colorectal Cancer Oleksandr Kvasivka (Ukraine)
Sep 5 (Thu) 07:00-07:40

[PP04] Poster Presentation

Hall B2, 1F
Chairperson(s)
Junchul Chung (Korea), Young Hoon Roh (Korea)
07:00-07:05
Effects of Pancreatectomy on Nutritional State, Pancreatic Function and Quality of Life for 5 Years Follow-Up Yong Chan Shin (Korea)
07:05-07:10
Solid Pseudopapillary Neoplasm of the Pancreas – A 16 Years North indian Tertiary Care Experience Kailash Kurdia (India)
07:10-07:15
Comparison of Robot and Open Pancreaticodenectomy for the Treatment Primary Duodenal Adenocarcinoma Wei Wang (China)
07:15-07:20
Towards Universal No Pancreaticojejunostomy Leak Kourosh Kojouri (United States)
07:20-07:25
A Comparative Analysis of Laparoscopic Splenic Vessel-Preserving vs Warshaw Distal Pancreatectomy M Fatih Can (Turkey)
07:25-07:30
Effect of Postoperative Pancreatic Fistula on Morphological and Functional Changes of Remnant Pancreas Following Pancreaticoduodenectomy Sunjong Han (Korea)
07:30-07:35
Yonsei-10 Year Experiences of Minimally Invasive Radical Distal Pancreatectomy for Left-Sided Pancreatic Cancer Hyeo Seong Hwang (Korea)
07:35-07:40
Central Pancreatectomy – A Janus Bifrons. A Comprehensive, Up-to-Date Systematic Review and Meta-Analysis of Comparative Studies with Distal Pancreatectomy Traian Dumitrascu (Romania)
Sep 5 (Thu) 07:00-07:40

[PP05] Poster Presentation

Hall B2, 1F
Chairperson(s)
Keun Soo Ahn (Korea), Erik Prabowo (Indonesia)
07:00-07:05
Novel Single-Layer Continuous Suture of Pancreaticojejunostomy for Robotic Pancreaticoduodenectomy Qu Liu (China)
07:05-07:10
Association of Adjuvant Radiotherapy with Survival After Margin-Negative Resection of Pancreatic Ductal Adenocarcinoma: A Propensity-Matched National Cancer Database (NCDB) Analysis Hari Nathan (United States)
07:10-07:15
The Change of Carbohydrate Antigen 19-9 as a Prognostic Marker After Neoadjuvant Chemotherapy in Patients with Borderline Resectable and Locally Advanced Pancreatic Cancer Woohyung Lee (Korea)
07:15-07:20
Harmonic Pancreatic Transection Increases Biochemical Leak But Not Postoperative Pancreatic Fistula in Pancreatoduodenectomy Chienhui Wu (Taiwan)
07:20-07:25
The Pilot Study of the Shark Mouth Pancreaticojejunostomy-A New Enteric Reconstruction Procedure of Pancreatic Stump Dianrong Xiu (China)
07:25-07:30
Modified Predicting System Combined Preoperative Anthropomorphic Imbalance with Fistula Risk Score for Clinically Relevant Postoperative Pancreatic Fistula After Pancreaticoduodenectomy Tomoyuki Abe (Japan)
07:30-07:35
Impact of Modified Physiobiological Parameter-Based Grading System on Long-Term Prognosis for Resectable Pancreatic Cancer Following Curative Surgery Tomoyuki Abe (Japan)
07:35-07:40
Optimal Timing of Pancreaticoduodenectomy Following Preoperative Biliary Drainage Considering Major Morbidity and Postoperative Survival Sang Hyun Shin (Korea)
Sep 5 (Thu) 07:00-07:40

[PP06] Poster Presentation

Hall B2, 1F
Chairperson(s)
Kwangyeol Paik (Korea), Masayuki Ohtsuka (Japan)
07:00-07:05
Is It Significant for Surgical Treatment for Gallbladder Cancer with Jaundice? Ryota Higuchi (Japan)
07:05-07:10
Spectrum of Lymphnodal Involvement Following Extended Cholecystectomy and Its Correlation with pT Stage in Gallbladder Carcinoma Patients R N Naga Santhosh Irrinki (India)
07:10-07:15
Treatment of Resectable Hilar Cholangiocarcinoma: A Choice of Right- or Left-Side Hepatectomy Hye-Sung Jo (Korea)
07:15-07:20
Efficacy of Silk Sutures Compared with Non-Absorbable Polymer Clips for Cystic Duct Ligation in Laparoscopic Cholecystectomy: A Prospective Randomized Controlled Study Rapeephan Na Nan (Thailand)
07:20-07:25
Surgical Strategy for T1 and T2 Incidental Gallbladder Cancer: Nationwide Multicenter Survey in South Korea Seung Eun Lee (Korea)
07:25-07:30
Bile Microbiology and Antibiotic Susceptibilities in Acute Cholecystitis Seung Eun Lee (Korea)
07:30-07:35
Biliary Mapping Using Indocyanine Green Dye During Laparoscopic Cholescystectomy Vikash Vittal (India)
07:35-07:40
Gram Staining of Gallbladder Bile in Patients Undergoing Early Cholecystectomy for Acute Cholecystitis Yasunori Nishida (Japan)
Sep 5 (Thu) 07:00-07:40

[PP07] Poster Presentation

Hall B2, 1F
Chairperson(s)
Chang-Sup Lim (Korea), Winston Woon (Singapore)
07:00-07:05
Prognostic Predictability of American Joint Committee on Cancer 8th Staging System for Perihilar Cholangiocarcinoma Jong Woo Lee (Korea)
07:05-07:10
Laparoscopic Cholecystectomy Combined with ERCP for Treatment of Mirizzi Syndrome Shang Yu Wang (Taiwan)
07:10-07:15
γH2AX Can Be a Biomarker to Distinguish Between Benign and Malignant Lesions in Bile Duct Biopsy Specimens Yuki Hirose (Japan)
07:15-07:20
Validation of Association Cystic Duct Fibrosis and Surgical Difficulty in Laparoscopic Cholecystectomy Hyung Hwan Moon (Korea)
07:20-07:25
What Features on Intra-Operative Cholangiogram Predict ERCP Outcome in Patients Post-Cholecystectomy Hugh Gao (Australia)
07:25-07:30
Study of Platelet Distribution Width as a Surrogate Marker for Diagnosis of Carcinoma of Gall Bladder: A Pilot Study from India Rohik Anjum T Siddeek (India)
07:30-07:35
Comparison of the Oncological Outcomes of Open Versus Laparoscopic Surgery for T1-T2 Gallbladder Cancer: A Propensity Score-Matched Analysis Jin Kyu Cho (Korea)
07:35-07:40
Portal Vein Embolization Combined with NACT Followed by Radical Surgery for Locally Advanced Gall Bladder Cancer Shivendra Singh (India)
Sep 5 (Thu) 07:00-07:40

[PP08] Poster Presentation

Hall B2, 1F
Chairperson(s)
Dae Wook Hwang (Korea), Tomoki Ebata (Japan)
07:00-07:05
Chronological Changes of Epidemiologic Features of Gallstone Over Last 20 Years in Korean Single Large Volume Center Jiyong Zhao (Korea)
07:05-07:10
Surgical Challenges in Mirizzi's Syndrome from Retained Cystic Duct - Common Bile Duct Junction Stones After Subtotal Cholecystectomy Yi Liang Wang (Singapore)
07:10-07:15
The Study of Outcomes of Biliary Duct Cancer After Hepatopancreatoduodenectomy Keisuke Okamura (Japan)
07:15-07:20
Infrahepatic Inferior Vena Cava Clamping During Liver Transection for Cholangiocarcinoma: A Quasi – Experimental Study Natwutpong Leeratanakachorn (Thailand)
07:20-07:25
Risk Factor of CBD Stone Recurrence After LCBDE. Is Related with CBD Angle? Sunyoung Park (Korea)
07:25-07:30
Laparoscopic Treatment of Mirizzi Syndrome with Concomitant Biliary Tract Anatomic Variation Chih Yao Hu (Taiwan)
07:30-07:35
Features of Clinical Manifestations and Diagnostics of Various Forms of Biliary Atresia in Infants Rustam Yuldashev (Uzbekistan)
07:35-07:40
Laparoscopic Resection of Biliary Cystic Tumours Sudeep Shah (India)
Sep 5 (Thu) 07:00-07:40

[PP09] Poster Presentation

Hall B2, 1F
Chairperson(s)
Geun Hong (Korea), Hiroyuki Nitta (Japan)
07:00-07:05
Living Liver Donor Surgical Complication: Single Center Experience with 512 Cases Eun-kyoung Jwa (Korea)
07:05-07:10
Donor Wound Satisfaction After Living Donor Liver Transplantation in the Era of Pure Laparoscopic Donor Hepatectomy Jeong-Moo Lee (Korea)
07:10-07:15
Impact of Donor Age on Recipient Recurrence Rate and Survival in Liver Transplantation Due to Hepatocarcinoma Mikel Prieto (Spain)
07:15-07:20
The Effect of Internal Stent to Reduce Duct Complication in Living Donor Liver Transplantation Ho Joong Choi (Korea)
07:20-07:25
Outcomes of Pediatric Deceased Donor Liver Transplantation: A Single-Center Experience Seisuke Sakamoto (Japan)
07:25-07:30
Indocyanine Green Retention Rate at 15 Minutes of 20% or Higher Can Be a Predictive Factor of Living Liver Donor with Right Hepatectomy? Yong-Kyu Chung (Korea)
07:30-07:35
Blockade Targeting CD47 Reduces Iri and Improves Survival in Liver Transplantation Model Zhenyu Xiao (China)
07:35-07:40
Planned Pregnancy and Childbirth After Living Donor Liver Transplantation (Case) Hyun Hwa Choi (Korea)
Sep 5 (Thu) 07:00-07:40

[PP10] Poster Presentation

Hall B2, 1F
Chairperson(s)
Dong-Sik Kim (Korea), Chih-Chi Wang (Taiwan)
07:00-07:05
A Novel Formula for Estimating Standard Liver Volume Using Anthropometric Parameters from Three Different Dimensions Po-Chih Yang (Taiwan)
07:05-07:10
Outcomes of a Tailored Rituximab-Based Desensitization Protocol Without Local Infusion Therapy for ABO-Incompatible Adult Living Donor Liver Transplantation Koji Natsuda (Japan)
07:10-07:15
Feasibility of Aorta After Endarterectomy as Middle Hepatic Vein Reconstruction in Living Donor Liver Transplantation Jae Hyun Kwon (Korea)
07:15-07:20
Excellent Outcome in Living Donor Liver Transplantation for Acute on Chronic Liver Failure Patients Yu-Chen Wang (Taiwan)
07:20-07:25
Minimal Invasive Living Donor Right Hepatectomy: An Experience of Consecutive 114 Cases by a Single Surgeon Sang Hyun Kang (Korea)
07:25-07:30
Eight Year Experience of an Emerging Liver Transplant Program in a Developing Country Marco Sumo (Philippines)
07:30-07:35
Donor Safety and Recipient Liver Function After Right-Lobe Liver Transplantation from Living Donors with Gilbert Syndrome Woo-Hyoung Kang (Korea)
07:35-07:40
Tolvaptan for Postoperative Fluid Management in Liver Transplantation Recipients Masahiro Shinoda (Japan)
Sep 6 (Fri) 07:00-07:40

[PP11] Poster Presentation

Hall B2, 1F
Chairperson(s)
Yang Seok Koh (Korea), Yoshihiro Sakamoto (Japan)
07:00-07:05
Elective Conversion Is Not Inferior to Planned Open Procedure During Laparoscopic Hepatectomy: Based on Latest Five-Year Data in a High-Volume Laparoscopic Center Long Pan (China)
07:05-07:10
Simultaneous Ipsilateral PVE and DSM-TACE as a Possible New Gold Standard Strategy for Preoperative Augmentation of Future Liver Remnant in Patients with Solid Liver Malignancies Oleksandr Korshak (Ukraine)
07:10-07:15
Aggressive Liver Resection for Multiple Bilober Colorectal Liver Metastases Including Parenchymal Sparing Hepatectomy and Repeat Hepatectomy Daisuke Hokuto (Japan)
07:15-07:20
The Value of Lymph Node Dissection for Intrahepatic Cholangiocarcinoma: A Systemic Review and Meta-Analysis Wei Zhang (China)
07:20-07:25
Complex Major Hepatectomy by Thunderbeat with the Pringle Maneuver and Infra-Hepatic Inferior Vena Cava Clamping Teruo Komokata (Japan)
07:25-07:30
Preoperative Serum Albumin Is Associated with Intra-Abdominal Infection Following Major Hepatectomy Narongsak Rungsakulkij (Thailand)
07:30-07:35
YAP Expression Maintains Putative Cancer Stemness and Is Associated with Poor Prognosis in Intrahepatic Cholangiocarcinoma Kensuke Sugiura (Japan)
07:35-07:40
Hepatic Vein Reconstruction for Parenchema-Sparing Resection of Advanced Hepatic Tumors Ruslan Alikhanov (Russia)
Sep 6 (Fri) 07:00-07:40

[PP12] Poster Presentation

Hall B2, 1F
Chairperson(s)
Jae Do Yang (Korea), Boonchoo Sirichindakul (Thailand)
07:00-07:05
Robotic Simultaneous Resection for Colorectal Liver Metastasis: Feasibility for All Types of Liver Resection Jonathan Navarro (Philippines)
07:05-07:10
Comparison of Intracorporeal and Extracorporeal Pringle Maneuver in Laparoscopic Hepatectomy for Hepatocellular Carcinoma Youliang Pei (China)
07:10-07:15
Surgical Treatment of Perihilar Cholangiocarcinoma with Vascular Invasion Oleksii Popov (Ukraine)
07:15-07:20
Prediction of Post-Hepatectomy Complications by Activity Change Pattern Hiroya Iida (Japan)
07:20-07:25
Development of a Radiomics Nomogram Based on the MRI Features to Predict the Survival of Hepatocellular Carcinoma Patients Yi-nan Shen (China)
07:25-07:30
Comparison of Laparoscopic and Open Hepatectomy for Patient with Hepatocellular Carcinoma and Child Grade B Liver Function Wanguang Zhang (China)
07:30-07:35
Validation of Liver Function and Prediction Scoring System Takafumi Kumamoto (Japan)
07:35-07:40
Resection Might Be a Meaningful Choice for HCC Patients with Portal Vein Thrombosis Han-hua Dong (China)
Sep 6 (Fri) 07:00-07:40

[PP13] Poster Presentation

Hall B2, 1F
Chairperson(s)
DongHee Ryu (Korea), Jonathan Koea (New Zealand)
07:00-07:05
Primary Prophylaxis of Esophageal Varices in Children with Non-Shuntable Portal Hypertension Rustam Yuldashev (Uzbekistan)
07:05-07:10
Fluorescence-Imaging in Hepato-Pancreatico-Biliary Surgery Katherine Panganiban (Philippines)
07:10-07:15
Initial Evaluation of the Protocol for the Liver Remnant After Major Hepatectomies with Liver Volumetry Using CT and Funtionality with Single Photon Emission Computed Tomography-Hepatobiliary Scintigraphy (mTc99-Mebrofenin) Mikel Prieto (Spain)
07:15-07:20
A New Treatment Modality for the Postoperative Muscular Pain Management in Pylorus Preserving Pancreaticoduodenectomy: A Double-Blind Randomized Control Trial Hyung Sun Kim (Korea)
07:20-07:25
The Incidence of Liver Abscesses After TAE for Patients with Postpancreatectomy Hemorrhages Hirokatsu Katagiri (Japan)
07:25-07:30
Postoperative Complications and Their Relationship with Malnutrition in Patients with Pancreas, Liver and Biliary Tumors Alejandro Eduardo Padilla Rosciano (Mexico)
07:30-07:35
Enhanced Recovery After Surgery (ERAS) and Adjuvant Chemotherapy Completion Rates After Pancreaticoduodenectomy (PD): A Retrospective Analysis Sharnice Koek (Australia)
07:35-07:40
Cytotoxicity of Human Hepatic Intrasinusoidal CD56bright Natural Killer Cells Against Hepatocellular Carcinoma Cells Shin Hwang (Korea)
Sep 6 (Fri) 07:00-07:40

[PP14] Poster Presentation

Hall B2, 1F
Chairperson(s)
Kwangsik Chun (Korea), Adrian Chiow (Singapore)
07:00-07:05
Minimally Invasive Distal Pancreatectomy Versus Open Distal Pancreatectomy in Benign and Low-Grade Malignant Pancreatic Tumor Based on Propensity Score Matching Analysis Cheng Xing (China)
07:05-07:10
The Role of Radical Antegrade Modular Pancreatosplenectomy Compared to Conventional Distal Pancreatosplenectomy in Patients with Left-Sided Pancreatic Ductal Adenocarcinoma: A Retrospective Multicenter Propensity- Score Matching Analysis Naru Kim (Korea)
07:10-07:15
Implementation of Early Recovery After Surgery (ERAS) Protocol in Chronic Pancreatitis Patients Undergoing Frey’s Procedure: A Prospective Study Kalayarasan Raja (India)
07:15-07:20
Multiplex Immunophenotyping Reveals Unique Characteristics of Pancreatic Neoplasms Timothy Frankel (United States)
07:20-07:25
Outcome of Minimally-Invasive Versus Open Pancreatectomies for Solid Pseudopapillary Neoplasms of the Pancreas: A 2:1 Matched Case-Control Study Hwee Leong Tan (Singapore)
07:25-07:30
Role of Laparoscopic Radical Antegrade Modular Pancreatosplenctomy for Adenocarcinoma of the Body and Tail of the Pancreas: A Retrospective Study Hanyu Zhang (China)
07:30-07:35
D-dimer as a Marker of Severity and Prognosis in Acute Pancreatitis Mario Victor Newton (India)
07:35-07:40
The Eighth AJCC N Classification for Exocrine Pancreatic Cancer Is a Superior Index Evaluating the Lymph Node Status in Patients with Pancreatic Neuroendocrine Tumors Mu-xing Li (China)
Sep 6 (Fri) 07:00-07:40

[PP15] Poster Presentation

Hall B2, 1F
Chairperson(s)
Jae Hoon Lee (Korea), David Cavallucci (Australia)
07:00-07:05
Treatment Outcomes for Stage 1 Pancreatic Cancer Shoji Kanno (Japan)
07:05-07:10
Critical Appraisal of the Impact of Individual Surgeon Experience on the Outcomes of Minimally Invasive Distal Pancreatectomies: Collective Experience of Multiple Surgeons at a Single Institution Grace Rui Si Lim (Singapore)
07:10-07:15
Comparison Between Different Predicting Systems for Pancreatic Fistula After Pancreaticoduodenectomy: Which Is Better? Hangyan Wang (China)
07:15-07:20
Adjuvant Therapy with Gemcitabine and Stereotactic Body Radiation Therapy Versus Gemcitabine Alone for Resected Stage II Pancreatic Cancer: A Prospective, Randomized, Open-Label, Single Center Trial Tao Ma (China)
07:20-07:25
Natural History of Pancreatic Cysts Managed via Surveillance Jia-Ying Jania Wu (Singapore)
07:25-07:30
The Superior Approach with Stomach Roll-Up Technique Has a Stimulating Effect on Learning of Laparoscopic Distal Pancreatectomy for Training Surgeons Takanori Morikawa (Japan)
07:30-07:35
Impact of Modified Duct to Mucosa (Buchler) vs Binding PJ (Pengs) Pancreaticojejunostomy on the Functional and Morphological Changes in Pancreatic Remnant After Pancreaticoduodenectomy - A Randomised Control Study Sri Venkata Pavaneswar Velineni (India)
07:35-07:40
Pancreatic Reconstruction Using a “Double U Stitch Pancreatogastrostomy” Following a Laparoscopic Whipple’s Pancreatoduodenectomy Amit Javed (India)
Sep 6 (Fri) 07:00-07:40

[PP16] Poster Presentation

Hall B2, 1F
Chairperson(s)
Yoo Shin Choi (Korea), Aswini Kumar Pujahari (India)
07:00-07:05
Initial Experience of Minimally Invasive Pancreaticoduodenectomy Min-Su Park (Korea)
07:05-07:10
Splenic Vein First Approach for Laparoscopic Spleen and Splenic Vessels Preserving Distal Pancreatectomy: The Learning Curve and Outcomes Ting-Kai Liao (Taiwan)
07:10-07:15
New Perspective on the Relationship Between Microorganism in Bile and Pancreatic Fistula in Patients Undergoing Pancreatoduodenectomy Kota Nakamura (Japan)
07:15-07:20
90-Day Readmission After Pancreaticoduodenectomy: A Single Tertiary Center Experience in Korea DooHun Kim (Korea)
07:20-07:25
Pathological Impact on the Stroma After Preoperative Chemotherapy with nab-Paclitaxel and Gemcitabine for Pancreatic Cancer Keinosuke Ishido (Japan)
07:25-07:30
Acute Pancreatitis with or Without Cholangitis - Implications on Antibiotic Protocols Yusoff Najim (Singapore)
07:30-07:35
Single Port Laparoscopic Distal Pancreatectomy Hyung Joon Han (Korea)
07:35-07:40
Preoperative Albumin: Globulin (A:G) Ratio in Patients Undergoing Whipple's Procedure- Predictor of Perioperative Morbidity or Prognosticator for Long Term Outcomes? Saiesh Reddy Voppuru (India)
Sep 6 (Fri) 07:00-07:40

[PP17] Poster Presentation

Hall B2, 1F
Chairperson(s)
Chi-Young Jeong (Korea), Sadiq S Sikora (India)
07:00-07:05
Correlation Between SUV Max Value Obtained by FDG-PET/CT and Pathological Findings in Cholangiocarcinoma Takafumi Yachi (Japan)
07:05-07:10
The Nature Course of Patients with Acute Cholecystitis Undergoing Percutaneous Transhepatic Gallbladder Drainage as Initial Treatment and Without Later Elective Cholecystectomy Feng-Ching Tsai (Taiwan)
07:10-07:15
Evaluating the Timing of Laparoscopic Cholecystectomy for Acute Cholecystitis Based on Propensity Score Matching Shintaro Teraoka (Japan)
07:15-07:20
Post-Hepatectomy Liver Failure Is Associated with Tumor Recurrence in Patients with Hilar Cholangiocarcinoma Eung Chang Lee (Korea)
07:20-07:25
Effects of Sarcopenia on Prognosis After Resection of Gallbladder Cancer Eung Chang Lee (Korea)
07:25-07:30
Evaluating the Advantages of Treating Acute Cholecystitis by Following TG18 Yauren Chang (Taiwan)
07:30-07:35
Effects of the Gross Types in Patients with T2 Gallbladder Cancer Insik Shin (Korea)
07:35-07:40
Management of Acute Cholecystitis Patients Receiving Antithrombotic Agents Takeshi Tomiyama (Japan)
Sep 6 (Fri) 07:00-07:40

[PP18] Poster Presentation

Hall B2, 1F
Chairperson(s)
Tae Ho Hong (Korea), Manabu Kawai (Japan)
07:00-07:05
Is Percutaneous Cholecystostomy Acceptable as a Bridge Treatment for Acute Cholecystitis in High Risk Patients Who Has a Biliary Problem? Kwangyeol Paik (Korea)
07:05-07:10
Post Cholecystecomy Biliary Injury, Management at Various Stages of Presentation Hamza Wani (India)
07:10-07:15
The Majority of Suspected Bile Duct Stones Can Be Managed at Time of Laparoscopic Cholecystectomy Kihoon Choi (Australia)
07:15-07:20
Impact of the Bile Duct Resection Margin Distance on Survival of Patients with Resected Extrahepatic Bile Duct Cancer Kil Hwan Kim (Korea)
07:20-07:25
Role of Routine Lymph Node Dissection in Macro-invasive Intraductal Papillary Neoplasm of the Bile Duct Vor Luvira (Thailand)
07:25-07:30
Posthepatectomy Liver Failure in Patients with Perihilar Cholangiocarcinoma Mikhail Efanov (Russia)
07:30-07:35
Bile Duct Injury During Cholecystectomy: Audit of 1,437 Laparoscopic and Open Cholecystectomy Setthabutr Eaupanitcharoen (Thailand)
07:35-07:40
Role of HER2NEU and EGFR as Prognostic Markers in Carcinoma Gall Bladder - A prospective study Sravya Ganti (India)
Sep 6 (Fri) 07:00-07:40

[PP19] Poster Presentation

Hall B2, 1F
Chairperson(s)
Dong Jin Joo (Korea), Yock Young Dan (Singapore)
07:00-07:05
Learning Curve of Laparoscopic Living Donor Right Hepatectomy to Mimic Open Procedure: Review of Single Surgeon’s 103 Laparoscopic Cases Compared to Open Cases Okjoo Lee (Korea)
07:05-07:10
Patients with Hepatorenal Syndrome May Have Better Renal Outcome After Living Donor Liver Transplantation Comparing with Patients with Chronic Kidney Disease Sheng-Chih Kuo (Taiwan)
07:10-07:15
Splenic Devascularization Can Replace Splenectomy During Adult Living Donor Liver Transplantation - A Historical Cohort Study Deok-Bog Moon (Korea)
07:15-07:20
Clamp-Crush Technique Versus Harmonic Scalpel for Hepatic Parenchymal Transection in Living Donor Hepatectomy: A Randomized Controlled Trial Ahmed Shehta (Egypt)
07:20-07:25
Outcome of ABO-Incompatible Adult Living-Donor Liver Transplantation for Patients with Hepatocellular Carcinoma Sang Hyun Kang (Korea)
07:25-07:30
Antioxidant Preconditioning Enhances Adipose Tissue-Derived Stem Cell Therapy by increasing Intrahepatic Engraftment for Liver Fibrosis Jingfeng Liu (China)
07:30-07:35
Strategy for Selective Middle Hepatic Vein Reconstruction in Living Donor Liver Transplantation Using Right Lobe Graft Sung Yeon Hong (Korea)
07:35-07:40
Long-Term Analysis of Biliary Complications After Duct-Toduct Sung Yeon Hong (Korea)
Sep 6 (Fri) 07:00-07:40

[PP20] Poster Presentation

Hall B2, 1F
Chairperson(s)
Jong Man Kim (Korea), Masaaki Watanabe (Japan)
07:00-07:05
ARRB1 Protects Against Hepatic Ischemia-Reperfusion Injury via Interaction with TRAF6 Xiaoliang Xu (China)
07:05-07:10
Efficacy and Superiority Between ERCP and PTBD as First Line Intervention of Biliary Complication After Liver Transplantation Minseob Kim (Korea)
07:10-07:15
The First Successful Recanalization of Complete Biliary Anastomotic Obstruction After Right Lobe LDLT with a Magnetic Compression Anastomotic Method Aidar Skakbayev (Kazakhstan)
07:15-07:20
Clinical Outcomes of Patients with Injuries of Adjacent Organs by Expanded Polytetrafluoroethylene Grafts Used for Middle Hepatic Vein Reconstruction in Right Lobe Living Donor Liver Transplantation: A Single-Center Real-World Experience Hye Young Woo (Korea)
07:20-07:25
Feasibility of Right Posterior Sector Graft in Living Donor Related Liver Transplant Rajeshkannan Selvam (India)
07:25-07:30
Predictive Factors of a Non-Recovery from Sepsis-3: Comparison with Sepsis-2 Kazuhisa Takeda (Japan)
07:30-07:35
Outcomes of Extrahepatic Recurrence After Adult Living Donor Liver Transplantation for Hepatocellular Carcinoma Byeong-Gon Na (Korea)
07:35-07:40
Portal Vein Thrombosis in Cirrhotic Patients Awaiting Liver Transplantation Hao-Chien Hung (Taiwan)